Sodium Hyaluronate PF 0.1% Nitten Uses

sponsored
How long did you take this medication to work?

What is Sodium Hyaluronate PF 0.1% Nitten?

Sodium Hyaluronate PF 0.1% Nitten is a family of injectable Sodium Hyaluronate PF 0.1% Nitten dermal fillers used to provide 9 months to one year of correction for moderate to severe facial wrinkles and folds, such as nasolabial folds (lines from the nose to the corners of the mouth). It is not indicated for use in lip augmentation.

Sodium Hyaluronate PF 0.1% Nitten products are a smooth consistency gel, compared to some hyaluronic gel products that have a granular consistency. Sodium Hyaluronate PF 0.1% Nitten products are developed using the Hylacross technology to allow a smoother, malleable gel. Sodium Hyaluronate PF 0.1% Nitten is a naturally occurring sugar found in the body. Sodium Hyaluronate PF 0.1% Nitten works by holding in water at the injection site and acting as a cushioning agent. It adds temporary volume and a smoother appearance to skin. Most patients need one treatment to achieve optimal results.

Some Sodium Hyaluronate PF 0.1% Nitten XC products also contain the local anesthetic lidocaine for a more comfortable injection. Sodium Hyaluronate PF 0.1% Nitten Ultra XC and Sodium Hyaluronate PF 0.1% Nitten Ultra Plus XC both contain 0.3% preservative-free lidocaine and numb the treatment area within seconds. The Sodium Hyaluronate PF 0.1% Nitten Ultra Plus products contain more highly cross-linked formulations for volumizing and correction of deeper folds and wrinkles.

Sodium Hyaluronate PF 0.1% Nitten indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

* Sores in the mouth, when applied to the skin as a gel.

* Eye surgery and corneal transplant, when injected by an eye surgeon.

Osteoarthritis, when injected into the joint by a healthcare provider. Despite being approved by the FDA for treatment of osteoarthritis by injection, results vary. Some people report a moderate improvement in joint stiffness and pain decrease with Sodium Hyaluronate PF 0.1% Nitten treatment, but this is not always the case. Whether Sodium Hyaluronate PF 0.1% Nitten might delay or lessen progressive joint damage with long-term use is unknown. Adjunctive therapy in: * Healing skin wounds and burns.

* Detached retina and other eye injuries.

* Preventing the effects of aging.

How should I use Sodium Hyaluronate PF 0.1% Nitten?

Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.

Do not share this medicine with another person, even if they have the same symptoms you have.

To use sodium hylauronate on the skin:

  • Clean and disinfect the skin area before applying sodium hyaluronate topical cream, gel, film, or spray.

  • Apply enough of the medication to cover the wound or affected skin area entirely.

  • If you use sodium hyaluronate gel, foam or cream on an open skin wound, dab a thin layer of the medicine onto the affected area with as little rubbing as possible.

  • To prevent contaminating the medication tube or bottle, use a sterile rubber glove or finger cot while applying sodium hyaluronate topical.

  • Cover the treated skin area with a sterile gauze pad or other dressing recommended by your doctor.

  • Sodium hyaluronate topical for use on the skin is usually applied 2 or 3 times per day. Follow your doctor's instructions.

To use the sodium hyaluronate oral gel:

  • Tear open the gel packet and pour the entire contents into a drinking glass. Add 1 or 2 tablespoons of water and stir this mixture well.

  • If you do not have water available while using the oral gel, you may use it undiluted.

  • Rinse your mouth thoroughly by swishing and gargling with the mixture in your mouth for at least 1 minute.

  • Make sure your gums, teeth, tongue, and insides of your cheeks are well coated with the medicine before spitting it out.

  • Avoid eating or drinking anything for at least 1 hour after using the oral gel.

  • Sodium hyaluronate oral gel may be used 3 times per day. Follow your doctor's instructions.

Stop using this medicine and call your doctor if your symptoms do not improve or if they get worse, or if you develop new symptoms.

Store at room temperature away from moisture and heat. Keep the tube bottle tightly closed when not in use. Do not tear open an oral gel packet until you are ready to use it.

Uses of Sodium Hyaluronate PF 0.1% Nitten in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Sodium Hyaluronate PF 0.1% Nitten is used to treat knee pain caused by osteoarthritis (a disorder of joints that causes stiffness, pain and loss of movement due to breakdown of lubricating fluid between joints) when treatment with common painkillers or other physical therapy (exercise, physiotherapy etc.) does not provide adequate relief. It is also used for treatment of mouth sores, prevention of skin aging and during cataract surgery.

Sodium Hyaluronate PF 0.1% Nitten description

Each bottle contains 100 mL soln plus 1 applicator for nasal use and 1 applicator for the use in the ear, sealed in a bag.

Inside the metal bottle, the soln remains isolated and not in contact with the propellant because it is contained within a bag made of nontoxic material. The propellant used is air and it is pressurized within the entire space surrounding the bag inside the metal bottle. The inhalation of Sodium Hyaluronate PF 0.1% Nitten occurs via valve positioned above the bag.

With the system: The air is used like a gas propellant, so Sodium Hyaluronate PF 0.1% Nitten does not damage the ozone layer. It is necessary to use preservatives so the possibility of allergic reaction is reduced. The bottle can be used in any direction so Sodium Hyaluronate PF 0.1% Nitten is practical and easy to use.

Sodium Hyaluronate PF 0.1% Nitten dosage

sponsored

Individualization Of Treatment

Severely indurated, sharply marginated and very superficial wrinkles may be difficult to distend and, therefore, are difficult to correct. If a defect cannot be distended because of extensive scarring or non-elastic tissue, the course of correction will be prolonged, if correction is achievable.

Touch-up implantations may be required in areas with greater motion or mechanical stress (e.g., nasolabial folds). All patients should be counseled to anticipate supplemental implantations to achieve and maintain optimal correction.

How supplied

Sodium Hyaluronate PF 0.1% Nitten gel is supplied in individual treatment syringes with needles, and is packaged for single patient use, ready for injection (implantation). The contents of the syringe are sterile and non-pyrogenic. The volume markings on the syringe are for reference only.

To Attach Needle To Syringe

  1. Peel sealed cover off the needle guard.
  2. Remove tip cap from syringe.
  3. Attach needle to syringe and twist to secure. To assure proper needle attachment, use the needles provided or 30-gauge needles with similar needle guards. Fully seat hub of needle in syringe. Do not over tighten, as this may break the needle and/or dislodge the syringe.
  4. Pull off the needle guard to expose needle.

Procedure To Change Needle

  1. Peel sealed cover off new needle guard.
  2. Twist used needle to disconnect it from the syringe.
  3. Attach new needle to syringe and twist to secure.
  4. Pull off the needle guard to expose needle.

To place an order, contact INAMED Corporation at (800) 624-4261.

Instructions For Use

  1. Sodium Hyaluronate PF 0.1% Nitten gel is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Prior to treatment with Sodium Hyaluronate PF 0.1% Nitten gel, the patient should be fully apprised of the indications, contraindications, warnings, precautions, treatment responses, adverse reactions, and method of administration. Patients also should be advised that supplemental “touch-up implantations may be required to achieve and maintain maximum correction.
  2. A complete medical history, including allergies, should be obtained to determine whether the patient is an appropriate candidate for Sodium Hyaluronate PF 0.1% Nitten treatment.
  3. The patient's soft tissue deficiencies should be characterized with regard to etiology, distensibility, stress at the site, and depth of lesion. Depending on the type of skin, best results are obtained when the defect is readily distensible and correction can be visualized by manual manipulation (stretching) of the skin. Pretreatment photographs are recommended.
  4. Topical or injectable anesthesia may be used to manage pain during and after injection.

  5. After ensuring that the patient has thoroughly washed the treatment area with soap and water, the area should be swabbed with alcohol or other antiseptic. Prior to injecting Sodium Hyaluronate PF 0.1% Nitten gel, depress the plunger rod until the product flows out of the needle.
  6. Sodium Hyaluronate PF 0.1% Nitten gel is administered using a thin gauge needle (30G ½”). The injection technique with regard to the angle and orientation of the bevel, the depth of injection, and the quantity administered may vary. A linear threading technique, serial puncture injections, or a combination of the two have been used to achieve optimal results. Subderma! application should be avoided because such application may not provide optimal correction. If Sodium Hyaluronate PF 0.1% Nitten gel is injected too deep, the duration of the effect will be shorter. If Sodium Hyaluronate PF 0.1% Nitten gel is injected too superficially this may result in visible lumps and/or discoloration.
  7. Inject Sodium Hyaluronate PF 0.1% Nitten gel applying even pressure on the plunger rod while slowly pulling the needle backwards. The wrinkle should be lifted and eliminated by the end of the injection. It is important that the injection is stopped just before the needle is pulled out of the skin to prevent material from leaking out or ending up too superficially in the skin.
  8. Only correct to 100% of the desired volume effect. Do not overcorrect. The degree and duration of the correction depend on the character of the defect treated, the tissue stress at the implant site, the depth of the implant in the tissue and the injection technique. Markedly indurated defects may be difficult to correct.
  9. If immediate blanching occurs, the injection should be stopped and the area massaged until it returns to a normal color.
  10. When injection is completed, the treated site should be gently massaged so that it conforms to the contour of the surrounding tissues. If an over correction has occurred, massage the area between your fingers or against an underlying superficial bone to obtain optima! results.
  11. if the wrinkle needs further treatment, the same procedure should be repeated until a satisfactory result is obtained. With patients who have localized swelling the degree of correction is sometimes difficult to judge at the time of treatment. In these cases, it is better to invite the patient to a touch-up session after 1-2 weeks.
  12. Patients may have mild to moderate injection site reactions, which typically resolve in a few days. If the treated area is swollen immediately after the injection, an ice pack can be applied to the site for a short period.
  13. After the initial treatment (from 1 to 2 weeks later), an additional treatment of Sodium Hyaluronate PF 0.1% Nitten gel may be necessary to achieve the desired level of correction. The need for an additional treatment may vary from patient to patient and is dependent upon a variety of factors such as wrinkle severity, skin elasticity and dermal thickness at the treatment site.
  14. The physician should instruct the patient to promptly report to her/him any evidence of problems possibly associated with the use of Sodium Hyaluronate PF 0.1% Nitten gel.

Storage

Sodium Hyaluronate PF 0.1% Nitten gel should be stored at room temperature, 2°-30°C (36°-86°F). DO NOT FREEZE.

Hyiaform gel has a clear appearance. In the event that a syringe contains material that is not clear do not use the syringe and notify INAMED Corporation immediately at (800) 624-4261.

Sterility

Sodium Hyaluronate PF 0.1% Nitten gel is packaged for single patient use. Do not resterilize. Do not use if package is opened or damaged.

Manufactured by: Genzyme Biosurgery, 1125 Pleasant View Terrace, Ridgefield, New Jersey 07657 USA. Distributed by: INAMED Aesthetics, 5540 Ekwill Street, Santa Barbara, CA 93111 USA (800) 624-4261

Sodium Hyaluronate PF 0.1% Nitten interactions

See also:
What other drugs will affect Sodium Hyaluronate PF 0.1% Nitten?

sponsored

To date, there are no reports of incompatibilities (interactions) of Sodium Hyaluronate PF 0.1% Nitten with other solutions for intra-articular administration. The patient may benefit from the concurrent use of oral analgesic and anti-inflammatory agents during the first days of treatment.

Incompatibiliies: There is a known incompatibility between sodium hyaluronate and quaternary ammonium salts eg, benzalkonium chloride which can be used as skin disinfectants. Sodium Hyaluronate PF 0.1% Nitten must therefore never come into contact with such products, nor with medical or surgical equipment treated with these types of products, since Sodium Hyaluronate PF 0.1% Nitten can precipitate in their presence.

Sodium Hyaluronate PF 0.1% Nitten side effects

See also:
What are the possible side effects of Sodium Hyaluronate PF 0.1% Nitten?

Clinical Evaluation of Sodium Hyaluronate PF 0.1% Nitten Gel

In a randomized, controlled clinical trial to evaluate the safety and effectiveness of Sodium Hyaluronate PF 0.1% Nitten gel as a dermal filler for nasolabial folds, 261 patients 30 to 55 years of age were randomized between the treatment (Sodium Hyaluronate PF 0.1% Nitten) and the control (Zyplast) implant. During the initial phase of the study, each patient was injected with the respective dermal filler in the nasolabial folds for wrinkle correction. Patients were followed for 12 weeks. Following completion of the initial phase, each of the patients who initially received Sodium Hyaluronate PF 0.1% Nitten gel treatment was offered repeat treatment with Sodium Hyaluronate PF 0.1% Nitten products in both nasolabial folds and evaluated for safety for an additional 4 weeks.

Initial Treatment Phase

Adverse events reported during the 12 weeks following treatment were categorized according to the reported severity.

Table 1 : Injection Procedure Related Adverse Events by Maximum Severity Occurring in > 5% of Patients [Number (%) of Patients]

Primary System Organ Class/ Preferred Term Sodium Hyaluronate PF 0.1% Nitten Total Zyplast Total Sodium Hyaluronate PF 0.1% Nitten

N = 133

Zyplast

N = 128

Mild Mod* Severe Mild Mod* Severe
At least 1 adverse event 111

(84)

109

(85)

105

(79)

6

(5)

0

(0)

105

(82)

2

(2)

2

(2)

General disorders and administration site conditions 111

(84)

109

(85)

105

(79)

6

(5)

0

(0)

105

(82)

2

(2)

2

(2)

Injection site erythema 84

(63)

86

(67)

83

(62)

1

(1)

0

(0)

85

(66)

1

(1)

0

(0)

Injection site bruising 54

(41)

39

(30)

52

(39)

2

(2)

0

(0)

37

(29)

2

(2)

0

(0)

Injection site swelling 47(35) 53

(41)

45

(34)

2

(2)

0

(0)

52

(41)

1

(1)

0

(0)

Injection site pain 42

(32)

29

(23)

40

(30)

2

(2)

0

(0)

26

(20)

1

(1)

2

(2)

Injection site pruritus 10

(8)

11

(9)

10

(8)

0

(0)

0

(0)

11

(9)

0

(0)

0

(0)

Injection site desquamation 3

(2)

7

(6)

3

(2)

0

(0)

0

(0)

7

(6)

0

(0)

0

(0)

*Mod = Moderate

Table 2: Duration of Procedure or Device Related Events Occurring in Greater thaii 5% of Patients

Primary System Organ Class/ Preferred Term Sodium Hyaluronate PF 0.1% Nitten gel

n = 133

n (%)

Zyplast

n = 128

n (%)

Duration* ≤ 3 days 4-7 days 8-14 days > 14 days Total ≤ 3 days 4-7 days 8-14 days > 14 days Total
Injection site erythema 53

(40)

16

(12)

13

(10)

2

(2)

84

(63)

59

(46)

11

(9)

5

(4)

11

(9)

86

(67)

Injection site bruising 19

(14)

23

(17)

10

(8)

2

(2)

54

(41)

10

(8)

21

(16)

5

(4)

3

(2)

39

(31)

Injection site swelling 31

(23)

12

(9)

4

(3)

00 47

(35)

38

(30)

12

(9)

00 3

(2)

53

(41)

injection site pain 39

(29)

2

(2)

1

(1)

00 42

(32)

22

(17)

5

(4)

1

(1)

1

(1)

29

(23)

Injection site pruritus 8

(6)

00 1

(1)

2

(2)

11

(8)

7

(6)

2

(2)

2

(2)

00 11

(9)

Injection site desquamation 1

(1)

1

(1)

1

(1)

00 3

(2)

3

(2)

3

(2)

1

(1)

00 7

(6)

*Duration refers to number of days irrespective of onset of Adverse Event to the date of the study device implantation

Device related adverse events occurred infrequently in both groups and were primarily of mild intensity; 2 patients (2%) experienced 3 events in the Sodium Hyaluronate PF 0.1% Nitten group, and 9 patients (7%) experienced 14 events in the Zyplast group. The Sodium Hyaluronate PF 0.1% Nitten device related adverse events were erythema, induration and pruritus.

Clinical trial adverse events unrelated to the injection procedure reported in the Sodium Hyaluronate PF 0.1% Nitten treatment group occurring in greater than 1% of patients (n=133) were nasopharyngitis (5.3%), headache (4.5%), influenza (3.8%), rash (3%), conjunctivitis (1.5%), and sinusitis (1.5%).

Repeat Treatment Phase

During the initial and repeat treatment phases of the study, hylan B IgG antibody titers were measured at baseline and throughout treatment. Only one patient exhibited a positive antibody response after treatment with hylan B. This patient experienced adverse events of injection site bruising and headache lasting 11 days and 2 days after initial treatment, respectively. These adverse events were not reported as device-related and were not considered to be associated with the increased antibody titer level. None of the other study patients developed similar increases in antibody titer levels during the initial or repeat study phases.

Of the 133 patients treated with Sodium Hyaluronate PF 0.1% Nitten gel during the initial phase, 96 underwent repeat treatment with Sodium Hyaluronate PF 0.1% Nitten products and were followed for up to 4 weeks for safety. The types of adverse events seen after repeat treatment with Sodium Hyaluronate PF 0.1% Nitten products were similar to those seen during the initial clinical evaluation. The most frequently reported adverse events included injection site erythema, bruising, swelling, pain, nodules, pruritus and tenderness. Device-related adverse events were reported in 3 patients during repeat treatment with Sodium Hyaluronate PF 0.1% Nitten gel and included involuntary muscle contraction described as eye fasciculations in one patient and dizziness in another. A third patient experienced bilateral aseptic abscess formation at the site of injection, but did not develop increased hylan B antibody titers throughout either the initial or repeat phase of the study.

Surveillance outside the US

Sodium Hyaluronate PF 0.1% Nitten post market safety surveillance in countries outside of the United States indicates that the most frequently reported adverse events include: injection site erythema, nodule, swelling, and induration. These adverse events are similar in frequency and duration to what has been noted during clinical trials.

Sodium Hyaluronate PF 0.1% Nitten contraindications

See also:
What is the most important information I should know about Sodium Hyaluronate PF 0.1% Nitten?

  • Sodium Hyaluronate PF 0.1% Nitten gel is contraindicated for use in breast augmentation, or for implantation into bone, tendon, ligament, or muscle,
  • Sodium Hyaluronate PF 0.1% Nitten gel is contraindicated for patients with a history of known hypersensitivity to avian proteins.
  • Sodium Hyaluronate PF 0.1% Nitten gel must not be injected into blood vessels. Introduction of Sodium Hyaluronate PF 0.1% Nitten gel into the vasculature may occlude the vessels and could cause infarction or embolization.

Active ingredient matches for Sodium Hyaluronate PF 0.1% Nitten:

Hyaluronic Acid in Japan.


List of Sodium Hyaluronate PF 0.1% Nitten substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
SportVis / pre-filled syringe 1.2 mL x 2's (Axelia Healthcare)
Solution; Ophthalmic; Hyaluronate Sodium 1% (Mylan)
Suplasyn md / pre-filled syringe 7 mg/0.7 mL x 1's (Mylan)
Suplasyn md 7 mg/0.7 mL x 3's (Mylan)
Suplasyn md 7 mg/0.7 mL x 5's (Mylan)
Suplasyn / pre-filled syringe 20 mg/2 mL x 1's (Mylan)
Suplasyn 20 mg/2 mL x 3's (Mylan)
Suplasyn 20 mg/2 mL x 5's (Mylan)
Suplasyn 20 mg/2 mL x 1's (Mylan)
Suplasyn 0.7 mg/0.7 mL x 1's (Mylan)
Suplasyn 60 mg/6 mL x 1's (Mylan)
Suplasyn 2 mL x 1's (Mylan)$ 49.60
Suplasyn inj 10 mg 2 mL x 1's (Mylan)
Suplasyn inj 10 mg 6 mL x 1's (Mylan)
Solution; Ophthalmic; Hyaluronate Sodium 1%
Solution; Ophthalmic; Hyaluronate Sodium 1%
Solution; Ophthalmic; Hyaluronate Sodium 1% (Asofarma)
Injectable; Injection; Hyaluronate Sodium 10 mg / ml
SYNJECT Prefilled Syringe / 0.01 / 2ml units (Gland Pharma Limited)$ 23.81
1 % w/v x 2 mL x 1's (Gland Pharma Limited)$ 23.81
Synject 1% w/v x 2mL INJ / 1 (Gland Pharma Limited)$ 23.81
Synject 20 mg Injection (Gland Pharma Limited)$ 11.90
SYNJECT 1% INJECTION 1 vial / 2 ML injection each (Gland Pharma Limited)$ 12.40
SYNJECT inj 1 % w/v x 2 mL x 2ml (Gland Pharma Limited)$ 23.81
Synject 1% w/v x 2mL INJ / 1 (Gland Pharma Limited)$ 23.81
Synject 1% Injection (Gland Pharma Limited)$ 6.20
Synocrom Forte 2 % x 1's (Dee)
Synocrom 1 % x 1's (Dee)

References

  1. PubChem. "HYALURONIC ACID". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  2. DrugBank. "HYALURONIC ACID". http://www.drugbank.ca/drugs/DB08818 (accessed September 17, 2018).
  3. MeSH. "Adjuvants, Immunologic". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Sodium Hyaluronate PF 0.1% Nitten are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Sodium Hyaluronate PF 0.1% Nitten. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 8 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2021 ndrugs.com All Rights Reserved